{"transactions":[{"id":683398,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T22:21:39.000Z","date":"2026-08-15","kind":"grant","planned":false,"acquired":true,"shares":215517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on August 15, 2027, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 681,087 shares issuable upon settlement of DSUs granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date."}],"balance_after":733136,"source":{"system":"sec-edgar","filing":"0001975134-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000197513426000001/primary_doc.xml","form_type":"4"}},{"id":995598,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T22:24:53.000Z","date":"2025-11-15","kind":"grant","planned":false,"acquired":true,"shares":158228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and will vest on November 15, 2026, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 465,570 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates."}],"balance_after":517619,"source":{"system":"sec-edgar","filing":"0001975134-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000197513425000003/primary_doc.xml","form_type":"4"}},{"id":1429246,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T20:40:32.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2025, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 307,342 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates."}],"balance_after":359391,"source":{"system":"sec-edgar","filing":"0001235802-24-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580224000068/primary_doc.xml","form_type":"4"}},{"id":1803471,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-17T20:18:49.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":28230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."}],"balance_after":28230,"derivative":{"exercise_price":1.2,"expiration_date":"2033-08-15","underlying":"Common Stock","underlying_shares":28230},"source":{"system":"sec-edgar","filing":"0001235802-23-000091","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580223000091/primary_doc.xml","form_type":"4"}},{"id":1803470,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T20:18:49.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":145180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 145,180 shares issuable upon settlement of deferred stock units granted under the Xtant Medial Holdings, Inc. 2023 Equity Incentive Plan and 52,049 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining a director of Xtant through the vesting dates."}],"balance_after":197229,"source":{"system":"sec-edgar","filing":"0001235802-23-000091","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580223000091/primary_doc.xml","form_type":"4"}},{"id":1891408,"issuer":{"id":7196,"kind":"organization","name":"Xtant Medical Holdings, Inc."},"owners":[{"id":22201,"kind":"person","name":"Beeson Jonn R.","position":1,"cik":"0001975134","reported_name":"Beeson Jonn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T21:02:48.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":52049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan, (as amended from time to time), and vest and become issuable on May 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan, (as amended from time to time), and vest and become issuable on May 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date."}],"balance_after":52049,"source":{"system":"sec-edgar","filing":"0001235802-23-000054","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453593/000123580223000054/primary_doc.xml","form_type":"4"}}]}